JCI vs MDGL · P/E 44, rev $23.60B vs rev $675.6M
Johnson Controls International PLC (JCI) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the JCI and MDGL stock pages for the full models.
Not investment advice.